The report analyzes and
presents an overview of " Ovarian Cancer Global Clinical Trials
Review, H1, 2016
"
worldwide.
GlobalData's
clinical trial report, Ovarian Cancer Global Clinical Trials Review,
H1, 2016" provides an overview of Ovarian Cancer clinical trials
scenario. This report provides top line data relating to the clinical
trials on Ovarian Cancer. Report includes an overview of trial
numbers and their average enrollment in top countries conducted
across the globe. The report offers coverage of disease clinical
trials by region, country (G7 & E7), phase, trial status, end
points status and sponsor type. Report also provides prominent drugs
for in-progress trials (based on number of ongoing trials).
GlobalData Clinical Trial Reports are generated using GlobalDatas
proprietary database - Pharma eTrack Clinical trials database.
Clinical trials are collated from 80+ different clinical trial
registries, conferences, journals, news etc across the globe.
Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
View
Report At :http://www.marketresearchreports.biz/analysis/741518
Scope
- The report provides a
snapshot of the global clinical trials landscape
- Report provides top level
data related to the clinical trials by Region, Country (G7 & E7),
Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top
companies involved and enlists all trials (Trial title, Phase, and
Status) pertaining to the company
- The report provides all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment
- The Report provides
enrollment trends for the past five years
- Report provides latest news
for the past three months
Reasons to buy
- Assists in formulating key
business strategies with regards to investment
- Helps in identifying
prominent locations for conducting clinical trials which saves time
and cost
- Provides top level analysis
of Global Clinical Trials Market which helps in identifying key
business opportunities
- Supports understanding of
trials count and enrollment trends by country in global therapeutics
market
- Aids in interpreting the
success rates of clinical trials by providing a comparative scenario
of completed and uncompleted (terminated, suspended or withdrawn)
trials
- Facilitates clinical trial
assessment of the indication on a global, regional and country level
Download
Sample copy of this Report at
Table
of Contents
Table
of Contents 2
List
of Tables 4
List
of Figures 5
Report
Guidance 6
Clinical
Trials by Region 7
Clinical
Trials and Average Enrollment by Country 8
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top
Five Countries Contributing to Clinical Trials in Europe 11
Top
Countries Contributing to Clinical Trials in North America 12
Top
Five Countries Contributing to Clinical Trials in Middle East and
Africa 13
Top
Five Countries Contributing to Clinical Trials in Central and South
America 14
Clinical
Trials by G7 Countries: Proportion of Ovarian Cancer to Oncology
Clinical Trials 15
Clinical
Trials by Phase in G7 Countries 16
Clinical
Trials in G7 Countries by Trial Status 17
Clinical
Trials by E7 Countries: Proportion of Ovarian Cancer to Oncology
Clinical Trials 18
Clinical
Trials by Phase in E7 Countries 19
Clinical
Trials in E7 Countries by Trial Status 20
Clinical
Trials by Phase 21
In
Progress Trials by Phase 22
Clinical
Trials by Trial Status 23
Clinical
Trials by End Point Status 24
Subjects
Recruited Over a Period of Time 25
Clinical
Trials by Sponsor Type 26
Prominent
Sponsors 27
Top
Companies Participating in Ovarian Cancer Therapeutics Clinical
Trials 28
Prominent
Drugs 29
Latest
Clinical Trials News on Ovarian Cancer 30
May
02, 2016: Novogen Provides Update On Development Of Cantrixil 30
May
02, 2016: Celsion Announces Positive Data from the First Cohort of
Patients in the OVATION Study 30
Apr
29, 2016: SELLAS Life Sciences Group Announces Initiation of
Galinpepimut-S (WT1 Cancer Vaccine) Phase 1 Clinical Trial in
Combination with PD-1 Checkpoint Inhibitor for Patients with Ovarian
Cancer 31
Apr
25, 2016: Cerulean Announces Oral Presentation of CRLX101 Clinical
Data at Gynecologic Oncology 2016 Conference 32
Apr
21, 2016: Merrimack Unveils its Latest Antibody Directed
Nanotherapeutic, MM-310, at the 2016 AACR Annual Meeting 33
Apr
21, 2016: OncoMed Announces Clinical Data for ipafricept to be
Presented at the 2016 ASCO Annual Meeting 34
Apr
21, 2016: TapImmune Announces Phase 2 Ovarian Cancer Trial Study with
AstraZeneca/MedImmune and Sloan Kettering Cancer Institute 34
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment